BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Nov 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-09

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-09	Common Stock	M	45000	$17.33	Acquired	96322	Direct
2012-11-09	Common Stock	M	6979	$14.39	Acquired	103301	Direct
2012-11-09	Common Stock	M	35521	$17.54	Acquired	138822	Direct
2012-11-09	Common Stock	S	20000	$48.00	Disposed	118822	Direct
2012-11-09	Common Stock	S	50000	$48.5531	Disposed	68822	Direct
2012-11-09	Common Stock	S	17500	$48.5509	Disposed	51322	Direct
2012-11-12	Common Stock	M	1329	$38.00	Acquired	52651	Direct
2012-10-31	Common Stock	A	109	$21.76	Acquired	52760	Direct
2012-11-12	Common Stock	M	10137	$17.54	Acquired	62897	Direct
2012-11-12	Common Stock	S	1438	$48.701	Disposed	61459	Direct
2012-11-12	Common Stock	S	10137	$48.6304	Disposed	51322	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-09	Stock Option (Right to Buy)	$17.33	M	45000	Disposed	2017-06-06	Common Stock (45000)	Direct
2012-11-09	Stock Option (right to buy) Common Stock	$14.39	M	6979	Disposed	2019-06-11	Common Stock (6979)	Direct
2012-11-09	Stock Option (right to buy) Common Stock	$17.54	M	35521	Disposed	2016-11-19	Common Stock (35521)	Direct
2012-11-12	Stock Option (right to buy) Common Stock	$17.54	M	10137	Disposed	2016-11-19	Common Stock (10137)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $48.5 to $48.7. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $48.52 to $48.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), purchase period of May 1, 2012 to October 31, 2012.

F4: The price in Column 4 is a weighted average price. The prices actually received ranged from $48.7 to $48.701. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F5: The price in Column 4 is a weighted average price. The prices actually received ranged from $48.51 to $48.76. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F6: Original option grant vests 6/48ths on December 7, 2007 and 1/48th on the 7th day of every month thereafter.

F7: Original option grant vests 6/48ths on November 12, 2009 and 1/48th on the 12th day of every month thereafter.

F8: Original option grant vests 6/48ths on May 20, 2007 and 1/48th on the 20th day of every month thereafter.